Skip to main content
Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease.
Megadose CD34(+) cell grafts improve recovery of T cell engraftment but not B cell immunity in patients with severe combined immunodeficiency disease undergoing haplocompatible nonmyeloablative transplantation.
Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia.
Population-based newborn screening for severe combined immunodeficiency.
Hematopoietic stem cell transplantation for severe combined immunodeficiency diseases.
Inflammatory cytokines and the development of pulmonary complications after allogeneic hematopoietic cell transplantation in patients with inherited metabolic storage disorders.
High unbound mycophenolic acid concentrations in a hematopoietic cell transplantation patient with sepsis and renal and hepatic dysfunction.
B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia.
Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia.